Altra Indtl Mtn Cmn (AIMC) 28.60 $AIMC Ball Corporation

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Altra Indtl Mtn Cmn (AIMC) 28.60 $AIMC

Ball Corporation Looks Good on Capital Projects; Risks Stay
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:11AM CDT
Ball Corporation (BLL) will benefit from the successful execution of capital projects.
CCK: 54.25 (+0.17), BLL: 74.88 (-0.08), AVY: 75.86 (-0.71), AIMC: 28.60 (-0.10)

Deere (DE) Beats on Q2 Earnings & Sales, Tweaks 2016 View
Zacks Equity Research - Zacks Investment Research - Fri May 20, 7:53AM CDT
Deere's (DE) second-quarter fiscal 2016 earnings and sales topped the Zacks Consensus Estimate.
DE: 86.21 (-0.74), ALRM: 22.51 (+0.27), AIMC: 28.60 (-0.10), ALG: 62.84 (+0.27)

The Zacks Analyst Blog Highlights: Unifi, Rexnord, Powell Industries, Altra Industrial Motion and Columbus McKinnon
Zacks Equity Research - Zacks Investment Research - Thu May 19, 8:30AM CDT
The Zacks Analyst Blog Highlights: Unifi, Rexnord, Powell Industries, Altra Industrial Motion and Columbus McKinnon
CMCO: 15.71 (-0.16), AIMC: 28.60 (-0.10), POWL: 37.59 (-0.21), UFI: 26.87 (+0.23)

5 Industrial Stocks to Buy as Output Revs Up
Zacks Equity Research - Zacks Investment Research - Wed May 18, 9:53AM CDT
Industrial production in the U.S. climbed at the fastest pace in more than a year in April.
RXN: 21.83 (-0.26), CMCO: 15.71 (-0.16), AIMC: 28.60 (-0.10), POWL: 37.59 (-0.21), UFI: 26.87 (+0.23)

Astec (ASTE) Hits 52-Week High on Strong Q1 & Stable View
Zacks Equity Research - Zacks Investment Research - Wed May 18, 6:22AM CDT
Astec (ASTE) hit a 52-week high on strong first-quarter performance and stable outlook.
ALRM: 22.51 (+0.27), AIMC: 28.60 (-0.10), ASTE: 55.27 (-0.67), ALG: 62.84 (+0.27)

Deere (DE) to Report Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Tue May 17, 5:40AM CDT
Deere (DE) is slated to report second-quarter fiscal 2016 results on May 20.
NDSN: 86.96 (-0.84), DE: 86.21 (-0.74), WOR: 40.03 (-0.48), AIMC: 28.60 (-0.10)

Avery Dennison Hits 52-Week High: Time to Buy the Stock?
Zacks Equity Research - Zacks Investment Research - Fri May 13, 8:28AM CDT
Shares of Avery Dennison Corporation (AVY) scaled a new 52-week high of $76.75 on May 12.
BERY: 38.59 (-0.56), CCK: 54.25 (+0.17), AVY: 75.86 (-0.71), AIMC: 28.60 (-0.10)

21.9% Return Seen to Date on SmarTrend Altra Holdings Call (AIMC)
Comtex SmarTrend(R) - Thu May 12, 1:30PM CDT
SmarTrend identified an Uptrend for Altra Holdings (NASDAQ:AIMC) on February 17th, 2016 at $22.81. In approximately 3 months, Altra Holdings has returned 21.95% as of today's recent price of $27.81.
AIMC: 28.60 (-0.10)

Middleby (MIDD) Q1 Earnings Beat on Sales Growth, Up Y/Y
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:29AM CDT
The Middleby Corporation's (MIDD) first-quarter 2016 earnings of 96 cents per share surpassed the Zacks Consensus Estimate of 84 cents. Also, revenues of $516.4 million inched up 0.3% from the Zacks Consensus Estimate of $515 million.
MIDD: 126.07 (-0.45), GRC: 30.31 (+0.41), LXFR: 12.40 (-0.44), AIMC: 28.60 (-0.10)

Altra Industrial Motion (AIMC): The Perfect Mix of Value and Rising Earnings Estimates?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 7:40AM CDT
Altra Industrial Motion could be a great choice for value investors at this time as it has a low PE, P/S ratio, decent dividend yield and a solid Zacks Rank
AIMC: 28.60 (-0.10)

Colfax (CFX) Beats Q1 Earnings, Revenues; Retains '16 View
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:13AM CDT
Colfax Corporation's (CFX) first-quarter 2016 adjusted earnings of 30 cents per share surpassed the Zacks Consensus Estimate of 27 cents. Also, revenues of $877 million beat the Zacks Consensus Estimate by 6.3%.
CFX: 28.88 (-0.69), GRC: 30.31 (+0.41), LXFR: 12.40 (-0.44), AIMC: 28.60 (-0.10)

Xylem (XYL) Beats on Q1 Earnings, Provides FY16 Outlook
Zacks Equity Research - Zacks Investment Research - Tue May 03, 9:55AM CDT
Xylem Inc. (XYL) reported solid first-quarter 2016 results.
XYL: 46.30 (-0.16), GRC: 30.31 (+0.41), LXFR: 12.40 (-0.44), AIMC: 28.60 (-0.10)

AGCO Corp (AGCO) Down Despite Q1 Earnings & Sales Beat
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:41AM CDT
AGCO's (AGCO) first-quarter 2016 earnings & sales beat the Zacks Consensus Estimate.
AGCO: 54.54 (-0.35), ALRM: 22.51 (+0.27), AIMC: 28.60 (-0.10), TWI: 7.21 (-0.21)

Altra Reports First-Quarter 2016 Results
GlobeNewswire - Fri Apr 29, 6:07AM CDT
Altra Industrial Motion Corp. (Nasdaq:AIMC), a global manufacturer and marketer of electromechanical power transmission and motion control products, today announced unaudited financial results for the first quarter ended March 31, 2016.
AIMC: 28.60 (-0.10)

Ball Corporation (BLL) Q1 Earnings & Sales Miss Estimates
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 8:59AM CDT
Ball Corporation's (BLL) first-quarter 2016 earnings & sales missed the Zacks Consensus Estimate.
CCK: 54.25 (+0.17), BLL: 74.88 (-0.08), AVY: 75.86 (-0.71), AIMC: 28.60 (-0.10)

Altra Holdings Shares Up 27.0% Since SmarTrend's Buy Recommendation (AIMC)
Comtex SmarTrend(R) - Thu Apr 28, 12:49AM CDT
SmarTrend identified an Uptrend for Altra Holdings (NASDAQ:AIMC) on February 17th, 2016 at $22.81. In approximately 2 months, Altra Holdings has returned 27.03% as of today's recent price of $28.97.
AIMC: 28.60 (-0.10)

Rockwell Automation (ROK) Tops Q2 Earnings, Trims View
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:47AM CDT
Rockwell Automation, Inc. (ROK) reported Q2 adjusted earnings per share of $1.37, beating the Zacks Consensus Estimate of $1.32.
GWW: 227.17 (-3.44), AIMC: 28.60 (-0.10), TWI: 7.21 (-0.21), ROK: 118.74 (-0.28)

Avery Dennison (AVY) Tops Q1 Earnings, Raises 2016 View
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:46AM CDT
Avery Dennison's (AVY) first-quarter 2016 earnings beat but sales missed the Zacks Consensus Estimate.
AVY: 75.86 (-0.71), ACCO: 10.60 (+0.11), ALRM: 22.51 (+0.27), AIMC: 28.60 (-0.10)

Astec (ASTE) Beats Q1 Earnings Estimates, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:18AM CDT
Astec's (ASTE) first-quarter 2016 earnings beat but sales missed the Zacks Consensus Estimate.
ACCO: 10.60 (+0.11), ALRM: 22.51 (+0.27), AIMC: 28.60 (-0.10), ASTE: 55.27 (-0.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 5

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 8

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bryan Leon Joins Storm Properties to Elevate Acquisitions Team

Updated Category News Views 381

Storm Properties Welcomes Bryan Leon as New Hire Storm Properties Inc., recognized as a significant player in the development, ownership, and management of a variety of properties, is delighted to announce the addition of Bryan Leon to their team as Land Acquisitions Manager. This appointment comes as part of the company's ongoing strategy to strengthen its position in...

Continue Reading
Revolutionizing Trade Setups with Innovative Scanner Technology

Updated Category News Views 280

Revolutionizing Trade Setups with Innovative Scanner Technology Stock Market Guides is thrilled to introduce significant advancements to its cutting-edge stock scanner technology. The latest update empowers users by showcasing the historical track record of various trade setups it identifies, offering unparalleled insight to traders looking to enhance their market...

Continue Reading
EQT Life Sciences Champions $39 Million Investment in Aerska

Updated Category News Views 101

EQT Life Sciences Champions $39 Million Investment in Aerska Advancing RNA Therapeutics EQT Life Sciences has recently announced a significant milestone: leading a $39 million Series A financing round in Aerska. This funding will be instrumental in pushing forward Aerska’s innovative brain shuttle technology. Designed to optimize the delivery of RNA interference...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 160

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading
Innovative Partnership Forged for Enhanced Vehicle Safety

Updated Category News Views 185

Innovative Partnership Forged for Enhanced Vehicle Safety NOVOSENSE Microelectronics, a key player in the semiconductor industry known for its high-performance analog and mixed-signal chips, is joining hands with Continental Automotive Technologies to enhance vehicle safety systems. This collaboration aims to push the envelope in developing automotive-grade sensors that...

Continue Reading